Novartis Agrees to Buy Glaxo Oncology Unit for $16B

Novartis Agrees to Buy Glaxo Oncology Unit for $16B Play

April 22 (Bloomberg) –- Bloomberg’s Jonathan Ferro reports on Novartis buying Glaxo’s cancer drug assets and selling it’s animal health operation to Eli Lilly. He speaks to Anna Edwards and Mark Barton on Bloomberg Television’s “Countdown.” (Source: Bloomberg)

Feed Most Popular

  • On Air Now

    Inside Johnson & Johnson Watch Now

  • Next

    Titans at the Table: The Rise of Macau

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus